针对溶酶体的细菌外膜囊泡用于PD-L1的瘤特异性降解
Panpan Ji1, Pengying Wu2, Lantian Wang2
1Department of Digestive Surgery, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710032, China.
Small (Weinheim an der Bergstrasse, Germany)
|June 27, 2024
概括
工程外膜囊泡 (OMVs) 通过降解PD-L1来向结肠癌,释放抗瘤免疫力并延长存活时间. 这种新型纳米系统为癌症治疗提供了一个有前途的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 免疫检查点基因表达,如PD-L1,在结肠癌等癌症中驱动免疫抑制.
- 新型治疗策略对于改善患者预后至关重要.
研究的目的:
- 将外膜囊泡 (OMV) 设计成一个免疫检查点阻塞纳米系统.
- 为了增强抗瘤免疫力,改善癌症治疗.
主要方法:
- 来自格拉姆阴性细菌的OMVs是使用Lyp1-Traptavidin融合蛋白进行的.
- 向性联体 (Lyp1) 和生物化抗PD-L1/M6P被在OMV上.
- 使用工程OMVs诱导PD-L1的溶解体降解.
主要成果:
- 工程OMV成功准瘤组织.
- 反PD-L1和M6P同时定PD-L1到 lysosomes进行降解.
- 纳米系统增强了抗瘤免疫力,抑制了癌症生长,并在合成瘤模型中延长了生存时间.
结论:
- 一个基于OMV的模块化纳米系统被开发用于瘤向的免疫检查点封锁.
- 这个系统有效降解PD-L1,释放抗瘤免疫力.
- 工程OMV显示了改善结肠癌治疗结果的潜力.
相关概念视频
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Lysosomes
17.5K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
17.5K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


